Background
Muscle wasting (MW) occurs early and rapidly during the intensive care unit (ICU) stay and contributes significantly to the development of ICU acquired weakness described in 50 to 100% of critically ill survivors [
1]. In critically ill patients, Puthucheary et al. reported a 12.5% loss of
rectus femoris muscle cross-sectional area (CSA) 7 days after ICU admission, ascribed to an increased protein turnover and an imbalance between muscle protein synthesis and protein degradation [
2‐
4]. From a conceptual point of view, muscle mass assessment in critically ill patients may help to detect at-risk patients and predict the patient outcome given that low skeletal muscle mass in critically ill patients has been independently associated with prolonged mechanical ventilation, prolonged ICU and hospital length of stay and mortality [
5]. Furthermore, monitoring muscle mass during the ICU stay may allow physicians to successfully identify patients who would benefit the most from tailored nutritional interventions. Nevertheless, assessing body composition and more precisely lean mass remains challenging in this setting: different methods have been described and validated, but none of them can be applied in the ICU setting [
6]. Anthropometric measurements such as tricipital skin-fold thickness and mid-arm muscle circumference may underestimate sarcopenia in critically ill patients considering the high incidence of subcutaneous edema [
7]. Bioelectrical impedance is also subject to bias as it is linked to hydration status which makes it unreliable in the ICU [
8]. Computed tomography [
5], dual-energy X-ray absorptiometry [
9] and magnetic resonance imaging [
10] offer accurate estimations of muscle mass by analyzing a cross-section usually going through the third lumbar vertebrae. However, these imaging techniques are not compatible with bedside evaluation and require unnecessary radiations and perilous transports.
In the last decade, ultrasonography (US) has taken an increasing part in ICU daily patient management and has recently been suggested to measure muscle volume and architecture [
11,
12]. The estimations revealed good accuracy compared with reference methods [
13]. Therefore, US assessment may constitute a promising non-invasive bedside tool to measure muscle thickness instantaneously and repeatedly. Quadriceps muscle combined thickness evaluation is considered relevant because it has been described as a reliable reflection of muscle strength [
11,
14]. Parameters obtained with ultrasound measurements could help physicians to dynamically monitor lean mass evolution across the ICU stay and consequently adapt nutritional support [
15].
Existing data indicate acceptable reproducibility in healthy subjects; however only few data have been reported in critically ill patients [
16]. US is known to be operator-dependent and measurements may be biased by variability in muscle compression, in site selection or in image analysis [
17]. Two main measurement sites have been described in the literature: either at midpoint or at two-thirds of the length between the anterior superior iliac spine (ASIS) and the upper pole of the patella. No consensus has been made over the optimal protocol to assess quadriceps femoris muscle mass. Our main hypothesis is that US is a reliable tool to assess muscle wasting in critically ill patients.
The primary objective of this study is to assess the overall intra- and inter-observer reliability of quadriceps muscle thickness measured with ultrasound in a general population of critically ill patients; and more specifically, in two distinct measurement sites. The secondary objective is to describe the quadriceps muscle thickness evolution over the three first ICU weeks after admission and its association with nutritional intake.
Discussion
Bedside ultrasound muscle assessment may be a convenient non-invasive tool to evaluate muscle wasting in the critical care setting. We demonstrated that this technique was reproducible by an individual observer and accurate between different observers. We observed a higher intra and inter-observer reliability when evaluations were made at the two-thirds of the length between the ASIS and the patella, with ICCs considered as “almost perfect agreement” [
24]. Patients suffered a significant muscle loss of 16% within the first week of the ICU stay and 24% at D21.
These measurements, completed as a part of standard care, allowed us to closely monitor muscle wasting and to assess its chronology. The percentage of muscle thickness loss reported during the first week of ICU was consistent with previous studies [
3]. The ICCs calculated were in the same range compared to those found in the literature regarding healthy volunteers [
19], elderly patients [
25], stroke patients [
26], septic patients [
16] and critically ill patients with acute kidney injury [
27]. This study differs from previous work in various aspects. First, our patients had high severity scores (expected mortality of 44%), were mechanically ventilated and received aggressive treatments (neuromuscular-blocking agent, vasopressors) which made them highly susceptible to ICU MW, edema and fluid changes. Second, we have chosen to follow muscle wasting during a prolonged window of 21 days. Third, to our knowledge, our study is the first to compare the reliability of two different measurement sites in order to identify the most precise muscle assessment. Finally, we observed the relationship between muscle loss and nutritional intake which constitutes one of the main challenges for our future daily practice [
28]. Lowering the incidence of functional disability through nutritional interventions seems very promising.
Insufficient protein intake constitutes a major factor of ICU acquired weakness. In the critical care setting, the recommended daily protein intake fluctuates between 1.2 and 2.0 g/kg/day [
22,
23] but this target is rarely reached in current practice [
29,
30]. Our cohort reflects those conclusions with a median daily protein intake of 0.4 g/kg/day and only 7% of patients reaching the recommended protein intake. Furthermore, we did not find a correlation between caloric or protein deficiency and muscle mass change during the first week. A study [
29] assessing 119 critically ill patients compared an amino-acid intake of 0.8 g/kg/day or 1.2 g/kg/day delivered by parenteral nutrition. Higher amino-acid provision was associated with significant greater forearm muscle thickness evaluated by ultrasound. Therefore, a future study of the relationship between muscle loss, evaluated by
Rectus femoris CSA, and daily protein intake would be pertinent.
Our study presents several limitations. Restricting our measurements to
quadriceps femoris combined thickness and not carrying out
rectus femoris CSA measurements may constitute the first limit. Indeed, a recent trial published in 2017 [
30] highlighted the superiority of muscle CSA as a reliable proxy for muscle strength compared with muscle thickness. The main concern about muscle CSA assessment is the difficulty of obtaining a full image of the
rectus femoris muscle with conventional high frequency linear probes (6–12 MHz) which have limited depth penetration. A recent study [
31] demonstrated the accuracy of using a lower frequency (2–5 MHz) curvilinear ultrasound probe, known to have higher depth penetration with lower resolution, for the evaluation of
Rectus femoris CSA. Consequently, future studies could easily focus on that technique in order to predict functional outcome in critically ill patients. Furthermore, the fact that both observers were ultrasound trained physicians represents a second limit. Studying the reliability of measurements made by novice students and describing their learning curve could be an interesting extension of our work. The low number of blind dual operator assessments constitutes an additional limitation to this work and the presented results should be confirmed in higher scale studies. Finally, we previously stated that ICU survivors can suffer from long-term functional impairment and quality of life degradation [
32], therefore, the limited window of observation in the ICU may not be sufficient. Prolonged muscle loss assessment beyond ICU or hospital stay would shed light on the chronology of muscle wasting and on the possible therapeutic options at our disposal to optimize muscle health.
Finally, ultrasound assessment may constitute a reliable and objective tool to assess frailty and malnutrition in the ICU. Promoting this technique may raise physicians’ attention regarding the prompt onset of muscle loss in the ICU, could encourage them to introduce daily follow-ups in their protocols and motivate them to intervene through nutritional interventions or exercise training. A recent review concerning nutrition monitoring in the ICU insists on the prevention and the early detection of nutritional-related complication through the use of clinical, biological and technical tests. [
33] The implementation of such a bundle in the ICU has never been evaluated regarding patient outcome and could provide the basis of further investigation. Furthermore, our work could reinforce the strength of ultrasound assessment as an outcome to predict functional recovery for future randomized controlled trials (RCT) aimed to limit ICU muscle wasting. An article [
34] co-written by major ICU nutritional experts recently emphasized the need to use functional outcomes in future RCTs considering that the outcomes commonly studied (mortality, length of stay) may incorrectly reflect the effect of nutritional interventions.
In the last decades, major technological and pharmaceutical progress has helped to considerably lower ICU and in-hospital mortality at the cost of profound and long-term physical disabilities for survivors. Functional recovery and its assessment in critically ill patients should be, from now on, a major focus in future research.